Greenway Medical downgraded to Underperform from Neutral at Sterne Agee Sterne Agee downgraded Greenway Medical based on high relative valuation. Price target is $14.
News For GWAY From The Last 14 Days
Check below for free stories on GWAY the last two weeks.